A High Decipher Genomic Risk Score Is Associated with Major Pathological Progression in Patients Undergoing Active Surveillance for Prostate Cancer | Synapse
March 3, 2026
A High Decipher Genomic Risk Score Is Associated with Major Pathological Progression in Patients Undergoing Active Surveillance for Prostate Cancer
Key Points
Pathological progression is significantly associated with a high genomic risk score in prostate cancer patients.
Patients with high genomic risk scores showed a notable increase in disease progression rates over time.
Analysis across various clinical settings demonstrated the impact of genomic risk scores on patient outcomes.
The findings highlight the need for integrating genomic risk assessment in active surveillance for better patient management.